Clinically, the activation of PPARs stands as a significant strategy used to address insulin resistance and dyslipidemia, with PPAR gamma activation by TDZs and PPAR alpha activation by fibrates playing distinct roles [58]. This evidence concerns the gene PPARG and metabolic syndrome.